key: cord-0693130-i2bemue4 authors: Shah, Sanjiv R.; Kane, Staci R.; Elsheikh, Maher; Alfaro, Teneile M. title: Development of a Rapid Viability RT-PCR (RV-RT-PCR) Method to Detect Infectious SARS-CoV-2 from Swabs date: 2021-08-08 journal: J Virol Methods DOI: 10.1016/j.jviromet.2021.114251 sha: b8004a39aa78ec2f9ce2f2a6b05a36c0f89153ad doc_id: 693130 cord_uid: i2bemue4 Since the rapid onset of the COVID-19 pandemic, its causative virus, Severe Acute Respiratory Syndrome Coronavirus-2 (SARS-CoV-2), continues to spread and increase the number of fatalities. To expedite studies on understanding potential surface transmission of the virus and to aid environmental epidemiological investigations, we developed a rapid viability reverse transcriptase PCR (RV-RT-PCR) method that detects viable (infectious) SARS-CoV-2 from swab samples in <1 day compared to several days required by current gold-standard cell-culture-based methods. The method integrates cell-culture-based viral enrichment in a 96-well plate format with gene-specific RT-PCR-based analysis before and after sample incubation to determine the cycle threshold (C(T)) difference (ΔC(T)). An algorithm based on ΔC(T) ≥ 6 representing ∼ 2-log or more increase in SARS-CoV-2 RNA following enrichment determines the presence of infectious virus. The RV-RT-PCR method with 2-hr viral infection and 9-hr post-infection incubation periods includes ultrafiltration to concentrate virions, resulting in detection of <50 SARS-CoV-2 virions in swab samples in 17 hours (for a batch of 12 swabs), compared to days typically required by the cell-culture based method. The SARS-CoV-2 RV-RT-PCR method may also be useful in clinical sample analysis and antiviral drug testing, and could serve as a model for developing rapid methods for other viruses of concern. ; (ii) is subjective and may not be as clear as desired (Agol et al., 1998) ; and (iii) can be caused by other viruses present in the sample that can infect the cultured cells, thus interfering with detection of the target virus (Schmidt et al., 1978) . Limitations of current methods can make it difficult to quickly assess the SARS-CoV-2 survival period on real-world environmental surfaces and to understand surface transmission. This, in turn, seriously impacts environmental epidemiology investigations and transmission studies, where timely knowledge of the presence of infectious virus on a surface is J o u r n a l P r e -p r o o f critical. Therefore, a rapid, dependable, and accurate analytical method for detecting infectious SARS-CoV-2 in environmental surface samples (e.g., swabs) is needed. The ability to rapidly detect infectious SARS-CoV-2 would also be valuable for epidemiology investigations and environmental surveillance in healthcare and other facilities (e.g., prisons, nursing homes), and within communities. Here, we report development of a Rapid Viability-Reverse Transcriptase PCR (RV-RT-PCR) method for detection of infectious SARS-CoV-2 in hours, rather than several days typical of the currently used cell-culture-based methods. Two or more T-75 flasks (75 cm 2 ) were seeded by adding ~1 × 10 6 freezing the flasks at -80℃ for 10 min, and then thawing the flasks. The flasks were then rigorously shaken from side-to-side to dislodge the monolayer and disperse the host cells. The freezing/thawing/shaking process was repeated three times to lyse the cells and release the virions. Then, the contents of the flasks were removed using serological pipettes and pooled into one or more 50-mL conical tubes. The tube(s) were centrifuged at 3,000-5,000 rpm at 4℃ for 3-5 minutes to pellet cellular debris, and the supernatant was transferred to a new 50 mL conical tube. The tube was vortex-mixed and 0.5-mL aliquots were transferred into labeled cryovials for storage at -80℃. J o u r n a l P r e -p r o o f Cell culture preparation for TCID50 analysis included seeding approx. 20 Applying whereas, remaining timepoint wells/plates are incubated at 37℃ with 5% CO2 to the desired J o u r n a l P r e -p r o o f endpoint, and then processed as for the T0 plate. From the T0 and Tf RT-PCR data, an algorithm based on ∆CT ≥ 6 representing ~ 2-log or more increase in SARS-CoV-2 RNA following enrichment determines the presence of infectious virus in the sample ( Figure 1 ). Further, the method uses a short post-infection incubation (i.e., 9 hours rather than multiple days), since complete host cell lysis is not required to determine RNA replication using differential RT-PCR analysis. Sample. The blue curve labeled "Time 0 response CT (T0)" represents the initial SARS-CoV-2 RT-PCR response for RNA from virions in the sample used to infect the cell culture (immediately after the infection period). The red curve labeled "Endpoint response CT (Tf)" represents the SARS-CoV-2 RT-PCR response signifying viral propagation in cell culture and the resulting increase in RNA copies detected (shown by the The method steps are shown in Figure 2 with a description of these steps below. This schematic shows protocol steps used for mock swab swatch or swab samples spiked with different titers of SARS-CoV-2 for method development. Testing with viral suspension directly (not from swabs or swatches) started with the step labeled "Infect cells". The optimal infection and incubation periods were selected based on testing (as described in Sections 2.5 and 2.6, respectively). The 0.22-µm filtration step removes bacteria and fungi that could contaminate the cell-culture. UF = Ultrafiltration. Experiments with viral suspension were conducted to determine the optimal infection period for RV-RT-PCR method development. The 96-well cell culture plates were prepared 18-24 hr before an experiment as described above, with three or more wells per viral dilution and three wells for negative controls (without virus). The same plate layout was used for the T0 plate and each timepoint plate (i.e., T12 and T24). The plates were incubated at 37℃ with 5% CO2 overnight, and the cell monolayer was allowed to become ~100% confluent prior to addition of virus. Viral suspensions were prepared by thawing an aliquot (stored at -80℃) from the titered-stock and adding 2% FBS DMEM to yield the desired viral concentrations (in 0.1 mL to be added per well) in 5 mL conical tubes. Sufficient volume was prepared for 10-fold viral dilutions to confirm the starting viral titer by conducting TCID50 analyses (with 12 replicates of 0.1 mL each for each 10fold dilution). In some cases, 2-fold dilutions were also prepared for testing in RV-RT-PCR experiments to evaluate method sensitivity of detection. Next, the medium was removed from cell-culture plates by multichannel pipettor (8- The plate was then stored at -80℃ until RNA extraction was conducted. Experiments with swab swatches spiked with different viral concentrations were conducted to determine the optimal post-infection incubation period for RV-RT-PCR method development. Since the Puritan swabs (Guilford, ME; Cat. No. P25-88060-PF-UW-DRY) previously used for environmental norovirus sampling were in high demand for SARS-CoV-2 response and resources were largely put into clinical swab production, a sheet of the same foam material (~4-5 mm thick) was supplied by Puritan (as requested by CDC colleagues) to generate swatches for testing. Swatches were aseptically cut using sterile scissors into ~5 cm 2 however, since swatch filtrates were in PBS, 0.1-mL 2% FBS DMEM was also added to each well to provide proper medium conditions for viral infection. A larger retentate volume of 0.5-mL was used for method development to enable testing of multiple post-infection incubation periods (T0, T9, T12, etc.) from the same swatch UF-retentate, with 0.1-mL used for each incubation timepoint. For these experiments, an 0.1-mL aliquot was also available for TCID50 analysis from the same swatch UF-retentate, with 10-fold dilutions prepared in 2% FBS DMEM as described above. The protocol for swatches was used for experiments with Sani-MacroSwabs (Sanigen, Anyang, Gyeonggi-do, South Korea; www.sanigen.kr), which were made from similar materials to the Puritan swabs. In this case, swab tubes already contained 10-mL PBS with the swab shaft attached to the tube cap; therefore, 0.5 mL was removed prior to adding the viral dilution to the swab head and placing it back into the tube with PBS (mimicking how a surface sample would be processed). For this evaluation of the final RV-RT-PCR method, the UF-retentate volume was decreased from 0.5-mL to ~0.2-mL, which was split evenly between T0 and Tf (T9) analyses. As for viral suspension experiments, the starting viral concentrations for the two replicate swab experiments varied slightly based on different starting viral titers and viral recovery efficiencies (determined from swab samples processed in parallel for TCID50 analysis). These replicate swabs for TCID50 analysis were processed in the same way as those used for RV-RT-PCR analysis, and results were related to the titer of the viral stock to determine the percent recovery as described in Section 2.6. Furthermore, % recoveries from higher viral concentrations were averaged and used to estimate a starting viral concentration per swatch for lower viral concentrations where % recovery was not determined directly, since these concentrations were often typically below the TCID50 method detection limit. The If not analyzed immediately by RT-PCR, RNA extracts were stored at -80C for up to 5 days. with CT values. The overall SD equation was also used to determine the overall SD for average ∆CT from triplicate swatch or swab samples spiked with the same viral concentration. All work with SARS- The RV-RT-PCR results for viral suspension studies with 2-hr infection and 12-or 24-hr postinfection incubation (or simply, incubation) are summarized in Table 1 for the other experiment. Table S3 ). Therefore, a 2-hr infection period was selected for subsequent experiments focused on determining an optimal incubation period to achieve a better method sensitivity for actual environmental samples, which may contain low viral concentrations and interferents that negatively impact viral infection. Once the infection period was established (i.e., 2-hr), experiments were conducted using swab swatches to determine an optimal incubation period for method sensitivity. The same swab swatch with recovered suspension was used for both RV-RT-PCR and TCID50 analyses. Swatches were spiked using 0.5 mL from -3 and -3. After swatch processing, 0.5 mL UF-retentate was obtained, and 0.1 mL aliquots were added to T0, T9, and T12 cell culture plates. Additionally, 0.1 mL was used for TCID50 analysis (Section 2.3). Because actual sample analysis will use the entire recovered viral UF-retentate (0.2 mL), split into only two parts (0.1 mL each) for T0 and Tf, the "PFU for RV-RT-PCR Analysis" for this experiment are expressed based on 0.2 mL ( Table 2) , rather than 0.1 mL used for TCID50 analysis of swatch UF-retentates (Supplemental Table S4 ). Therefore, the "PFU for RV-RT-PCR Analysis" ranged from ~44 to 140 and ~14 to 78 for the 514 and 257 PFU/swatch concentrations, Avg. Avg. CT Values are based on TCID50 analysis of swatch UF-retentates using 0.2 mL as the total volume since 0.1 mL was used for T0 and 0.1 mL was used T9 for RV-RT-PCR analysis. Values with greater than 100% recovery are shown as greater than 100% PFU for 0.2 mL. c Avg. CT and SD are based on triplicate RT-PCR analyses from triplicate swatch samples per viral concentration. d SD represents the pooled SD which equals the square root of the following: (SD for T0 values squared plus the SD for the T9 values J o u r n a l P r e -p r o o f Using the optimized RV-RT-PCR method as described above (specifically with 2-hr infection/9hr incubation), actual swabs (Sani-MacroSwab) were tested with three SARS-CoV-2 dilutions including -3, -3.3, and -4 log10 relative to the virus stock (TCID50 10 5.25 /0.1 mL or ~1.24  10 5 PFU/0.1 mL), along with a negative control (without virus), using triplicate swabs per viral concentration or negative control. Swabs were processed as described for swab swatches; however, after vortex-mixing the tube, the recovered swab suspension (with virus) was concentrated by UF to ~0.2 mL instead of 0.5 mL and split in half between the appropriate cellculture wells on T0 and T9 plates, as for actual swab sample analysis, and processed as described (Section 2.7). In addition, recovery efficiency was determined separately by conducting TCID50 analysis of replicate swabs spiked with -2 and -3 log10 viral dilutions in triplicate. Recovery efficiency data was used to determine estimated PFU/swab concentrations. RV-RT-PCR results using the N1 and N2 assay for the first experiment are shown in Table 3 ; the negative control replicates were non-detect for both assays (data not shown). The estimated PFU/swab based on TCID50 analysis of the viral stock (~1.24  10 5 PFU/0.1 mL) were approximately 620, 310, and 62 for the three viral dilutions (Supplemental Table S8 Table S9 (N1 Assay) and Table S10 (N2 Assay). The data showed a less than 50 virions sensitivity of detection could be achieved with RV-RT-PCR analyses using the N1 and N2 assays. A replicate experiment was conducted with swabs using the optimized RV-RT-PCR method as Table S11 ). RV-RT-PCR results using the N1 and N2 assay for the replicate experiment are shown in Table 4 ; the negative control replicates were non-detect for both assays (data not shown). The T0 and T9 CT values for triplicate RT-PCR analyses from these experiments are included in Supplemental Table 3 . The SARS-CoV-2 RV-RT-PCR method was optimized with regard to: (i) 96-well Vero E6 cell culture density; (ii) swab processing by vortex-mixing, ultrafiltration concentration (up to ~50fold volume reduction so entire sample can be used for RV-RT-PCR analysis), and 0.22-micron filtration to remove microbial contaminants; (iii) sample splitting between T0 and T9 wells/plates; (iv) viral infection period ( Based on the results of this study, an estimated timeline for RV-RT-PCR-based analysis of swab samples is shown in Figure 3 . The timeline is shown for 22 samples plus controls, although the method's 96-well plate format has the potential for higher throughput capacity, where up to 96 samples and controls can be processed in two 96-well cell culture plates, one for T0 and one for T9. Such increased sample quantity, however, would increase the time-to-results for triplicate RT-PCR analyses for T0 and T9 for each sample, unless multiple PCR instruments were available. Furthermore, this timeline does not include initial Vero E6 cell growth and plating at optimum cell density. However, it is assumed that during an ongoing infection spread, the analytical laboratory would keep 96-well cell-culture plates ready for anticipated sample analysis. The multi-well plate format used in this method also enables a small footprint, which is highly desirable in a BSL-3 laboratory. This format requires less incubator space and generates less hazardous waste from (i) significantly fewer multi-well plates compared to cell-culture flasks/plates required for traditional methods, (ii) lower volumes of growth medium and reagents, and (iii) predominant use of micropipette tips for small volumes rather than large serological pipets used for traditional methods. The RV-RT-PCR method developed using the non-human primate kidney cell line, Vero E6, can also be adapted to various human cell lines for potential application for efficacy testing of antibody-based vaccines and anti-viral drugs, since more rapid and potentially more sensitive results can be obtained compared to current culture-based methods. Further, since the propagation of virus through traditional cell culture creates a potential selection pressure, especially as cultures are prolonged, this rapid method may be useful for characterization of SARS-CoV-2 variants via J o u r n a l P r e -p r o o f specific RT-PCR assays. Finally, the method can also serve as a model for developing rapid methods for other viruses of concern including both bioterrorism and public health threats. In the wake of the rapid, world-wide spread of the COVID-19 pandemic, a RV-RT-PCR method was developed in a 96-well format to detect infectious SARS-CoV-2 in swab samples in less than a day to help understand surface stability and potential transmission for epidemiological investigations. The RV-RT-PCR method integrates cell-culture-based enrichment of SARS-CoV-2 in a sample with viral gene-specific RT-PCR-based molecular analysis conducted before and after a short (9-hr) incubation to determine the presence of infectious virus based on ∆CT ≥ 6 (representing ~ 2-log or more increase in the SARS-CoV-2 RNA). Since post-infection-RT-PCR analysis is performed while the virus is replicating in the host cells and not after complete cell lysis, the method time-to-results is less than one day with detection sensitivity of <50 virions per swab sample. None. Scientific Brief: SARS-CoV-2 and Potential Airborne Transmission COVID-19: Frequently Asked Questions Symptomatic and asymptomatic viral shedding in pediatric patients infected with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) Virus shedding dynamics in asymptomatic and mildly symptomatic patients infected with SARS-CoV-2 Presymptomatic SARS-CoV-2 infections and transmission in a skilled nursing facility Case Study: Prolonged infectious SARS-CoV2 shedding from an asymptomatic immunocompromised individual with cancer Presymptomatic transmission of SARS-CoV-2 -Singapore Temporal dynamics in viral shedding and transmissibility of COVID-19 Duration and key determinants of infectious virus shedding in hospitalized patients with coronavirus disease-2019 (COVID-19) Quantifying SARS-CoV-2 transmission suggests epidemic control with digital contact tracing Asymptomatic COVID-19 patients can contaminate their surroundings: an environment sampling study Potential sources, modes of transmission and effectiveness of prevention measures against SARS-CoV-2 Aerosol and surface contamination of SARS-CoV-2 observed in quarantine and isolation care Detection of air and surface contamination by SARS-CoV-2 in hospital rooms of infected patients Aerosol and surface distribution of severe acute respiratory syndrome coronavirus 2 in hospital wards Air, surface environmental, and personal protective equipment contamination by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) from a symptomatic patient Environmental contamination by SARS-CoV-2 in a designated hospital for coronavirus disease 2019 Environmental contamination of SARS-CoV-2 in healthcare premises Air and surface contamination in non-health care settings among 641 environmental specimens of 39 COVID-19 cases Longitudinal monitoring of SARS-CoV-2 RNA on high-touch surfaces in a community setting Contamination of inert surfaces by SARS-CoV-2: persistence, stability and infectivity. A review Infectivity of SARS-CoV-2 and other coronaviruses on dry surfaces: Potential for indirect transmission A systematic review of surface contamination, stability, and disinfection data on SARS Transmission of SARS-CoV-2: A Review of viral, host, and environmental factors Stability of SARS-CoV-2 and other coronaviruses in the environment and on common touch surfaces and the influence of climatic conditions: A review The effect of temperature on persistence of SARS-CoV-2 on common surfaces Aerosol and surface stability of SARS-CoV-2 as compared with SARS-CoV-1 Prolonged infectivity of SARS-CoV-2 in fomites Increasing temperature and relative humidity accelerates inactivation of SARS-CoV2 on surfaces Detection and infectivity potential of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) environmental contamination in isolation units and quarantine facilities Evaluation of cell lines and immunofluorescence and plaque assay procedures for quantifying reoviruses in sewage Two types of death of poliovirus-infected cells: caspase involvement in the apoptosis but not cytopathic effect Comparative sensitivity of various cell culture systems for isolation of viruses from wastewater and fecal samples Rapid-viability PCR method for detection of live, virulent Bacillus anthracis in environmental samples Development of a rapid viability polymerase chain reaction method for detection of Yersinia pestis Rapid viability polymerase chain reaction method of Francisella tularensis ICC/PCR detection of enteroviruses and hepatitis A virus in environmental samples Development of an integrated cell culture--real-time RT-PCR assay for detection of reovirus in biosolids Assessment of adenovirus, hepatitis A virus and rotavirus presence in environmental samples in Florianopolis, South Brazil Investigating SARS-CoV-2 surface and air contamination in an acute healthcare setting during the peak of the COVID-19 pandemic in London A simple method of estimating fifty percent endpoints Coronaviruses: propagation, quantification, storage, and construction of recombinant mouse hepatitis virus Virus isolation and quantitation US CDC Real-Time Reverse Transcription PCR Panel for Detection of Severe Acute Respiratory Syndrome Coronavirus 2 We thank Brian McMinn (EPA) and Alan Lindquist (EPA) for technical review of this manuscript.We thank Emily Snyder, Worth Calfee, Nichole Brinkman, Lance Brooks, Christine Tomlinson, Tonya Nichols (all EPA), and Laura Rose (CDC) for their technical assessment of the research results.We thank Laura Rose (CDC) for helpful discussions and help in acquiring Puritan swab material.We acknowledge BEI Resources (NIAID, NIH) for the following materials: SARS-Related Supplementary material related to this article is present in this appendix.